217 related articles for article (PubMed ID: 10426591)
1. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter.
Güllü S; Gürses MA; Başkal N; Uysal AR; Kamel AN; Erdoğan G
Endocr J; 1999 Feb; 46(1):221-6. PubMed ID: 10426591
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules.
Morita T; Tamai H; Ohshima A; Komaki G; Matsubayashi S; Kuma K; Nakagawa T
J Clin Endocrinol Metab; 1989 Aug; 69(2):227-30. PubMed ID: 2753971
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
5. Serum thyroglobulin level in patients with diffuse and nodular goiter, after therapeutic application of stable iodine.
Djurica SN; Cirović M; Tasovac-Ponomarev D
Exp Clin Endocrinol; 1992; 99(1):21-5. PubMed ID: 1628693
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter.
Berghout A; Wiersinga WM; Smits NJ; Touber JL
Am J Med; 1990 Nov; 89(5):602-8. PubMed ID: 2239979
[TBL] [Abstract][Full Text] [Related]
7. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
[TBL] [Abstract][Full Text] [Related]
8. Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity.
Vermiglio F; Benvenga S; Melluso R; Catalfamo S; Princi P; Battiato S; Consolo F; Trimarchi F
J Endocrinol Invest; 1986 Oct; 9(5):389-96. PubMed ID: 3098822
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of goiter treatment with L-thyroxine in patients over 40].
Wollmann B; Meller J; Hüfner M; Becker W
Nuklearmedizin; 1998 Jan; 37(1):41-4. PubMed ID: 9467169
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
[TBL] [Abstract][Full Text] [Related]
11. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
12. Solitary nodular disease and multinodular goiter: a retrospective study on suppressive versus replacement levothyroxine therapy.
Paggi A; Persegani-Trimarchi C; Russo P; Mastropasqua M; Mosetti MA; Losi T; Leri O
Endocr Res; 1999 May; 25(2):229-38. PubMed ID: 10382684
[TBL] [Abstract][Full Text] [Related]
13. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
Celani MF
Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
[TBL] [Abstract][Full Text] [Related]
14. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
Papini E; Petrucci L; Guglielmi R; Panunzi C; Rinaldi R; Bacci V; Crescenzi A; Nardi F; Fabbrini R; Pacella CM
J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726
[TBL] [Abstract][Full Text] [Related]
15. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
Celani MF; Mariani M; Mariani G
Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885
[TBL] [Abstract][Full Text] [Related]
16. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
17. Increased serum thyroglobulin levels in patients with nontoxic goiter.
Pezzino V; Vigneri R; Squatrito S; Filetti S; Camus M; Polosa P
J Clin Endocrinol Metab; 1978 Apr; 46(4):653-7. PubMed ID: 755050
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules.
Kuo SW; Hu CA; Pei D; Ni KB; Shian LR
J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828
[TBL] [Abstract][Full Text] [Related]
19. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial.
Koc M; Ersoz HO; Akpinar I; Gogas-Yavuz D; Deyneli O; Akalin S
Clin Endocrinol (Oxf); 2002 Nov; 57(5):621-8. PubMed ID: 12390336
[TBL] [Abstract][Full Text] [Related]
20. [Therapy with L-thyroxine in thyroid struma. Study with ultrasonic evaluation].
Peta M; Cartasegna S; Fabiani MP; Macchi R; Vecchi G; Costantino D
Recenti Prog Med; 1989 Jun; 80(6):320-5. PubMed ID: 2672195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
